cough
mechan
protect
aerial
way
also
common
respiratori
symptom
children
adult
elaps
innumer
infecti
caus
tabl
infecti
tabl
character
dri
product
classifi
accord
durat
acut
less
week
subacut
week
chronicl
week
cough
paroxysm
harm
qualiti
life
patient
interven
sleep
provok
dysphonia
vomit
chronic
headach
urinari
incontin
anticough
mucolyt
mani
exempt
medic
laps
consum
medicin
world
offer
risk
advers
effect
poison
infanc
survey
made
casualti
north
american
disclos
poison
minor
year
provok
anticough
antiflu
predomin
case
children
two
five
year
toxic
exempt
anticough
laps
inconclus
data
clinic
taken
author
health
canada
contraind
minor
six
year
adopt
measur
secur
add
warn
papal
brief
care
use
children
year
standard
pack
bottl
test
open
child
follow
batcher
cup
brazil
warn
consist
papal
brief
anticough
use
lesser
children
two
year
age
pharmaceut
industri
oblig
use
pack
manuscript
test
children
manufactur
remov
worldwid
market
prevent
anticough
contend
hydrochlorid
clobutinol
risk
draw
interv
qt
induc
cardiac
arrhythmia
torsad
point
howev
activ
principl
still
commerci
otolaryngologist
use
take
care
case
follow
cough
pharyng
irrit
unchain
contact
perfum
inhal
variat
temperatur
act
speak
laugh
sing
frequent
physician
pediatrician
direct
patient
specialist
investig
syndrom
cough
airmail
superior
one
call
drip
afternas
everyth
necessari
otolaryngologist
know
scientif
neurophysiolog
cough
method
studi
pharmacolog
phonoaudiolog
treatment
relief
symptom
board
subject
revis
reflect
arc
cough
initi
respiratori
epithelium
diaphragm
pericardium
pleura
peritoneum
esophagu
stimul
mecanoreceiv
nociceptor
chemoreceptor
stapl
popul
consequ
also
evok
palpat
extern
auditori
meatu
commonli
wall
posteroinferior
one
ear
stimul
auricular
branch
vacant
nerv
nerv
arnold
experiment
anim
bilater
section
superior
laryng
nerv
modifi
consequ
cough
bilater
section
recurr
laryng
nerv
abolish
cough
provok
mechan
electr
stimul
mucou
larynx
superior
portion
trachea
interven
consequ
provok
acid
vapor
inhal
mechanoreceptor
low
threshold
answer
mechan
stimul
pulmonari
receiv
sprain
slowli
adapt
stretch
receptor
sar
rapidli
adapt
stretch
receptor
rar
activ
physiolog
variat
pulmonari
volum
breath
mechanossensor
esophag
tension
stimul
deglutit
patholog
condit
edema
mucosa
brochoconstrict
activ
receiv
small
sensit
chemic
stimul
acid
nociceptor
chemoreceptor
answer
chemic
stimul
capsaicin
bradicinin
prostaglandin
acid
heat
temperatur
extrem
mechan
stimul
myelin
stapl
fiber
fast
adapt
call
receiv
cough
import
paper
defens
aerial
way
therefor
sensibl
contact
liquid
main
particl
mucou
larynx
trachea
princip
bronchi
possess
distinct
physiolog
characterist
one
rar
sar
activ
capsaicin
believ
main
function
regul
consequ
cough
evok
extra
pulmonari
aerial
way
myelin
stapl
fiber
type
c
nociceptor
becom
vacant
numer
bronchi
lung
respons
bother
impuls
cough
express
ionic
canal
membran
transient
receiv
potenti
vanilloid
trpv
numer
also
larynx
transient
receiv
potenti
activ
directli
irrit
allicina
onion
garlic
isothiocyan
mustard
ideal
anticough
peripher
action
would
inhibit
stapl
fiber
c
select
abolish
patholog
paroxysm
cough
without
harm
physiolog
mechan
defens
stapl
fiber
aspir
could
occur
use
antagonist
ionic
canal
trpv
similar
medicin
local
anesthet
capabl
block
specif
sodium
canal
regul
voltag
thu
inhibit
potenti
action
stapl
fiber
current
line
research
new
anticough
test
molecul
action
affer
way
cough
converg
nucleu
solitari
treatment
brainstem
main
point
regul
consequ
break
multipl
neural
project
reticular
format
ambigu
nucleu
periaqueduct
ciner
substanc
dorsal
nucleu
experiment
model
cough
provok
stimul
mechan
trachea
intensifi
instil
capsaicin
nasal
mucou
esophag
indic
brainstem
integr
sensit
affer
triplet
nerv
nasal
mucou
wander
affer
tracheabronchi
would
one
predispos
mechan
cough
patient
sinonas
condit
syndrom
cough
airmail
superior
one
gastroesophag
reflux
glutam
seem
main
excitatori
neurotransmitt
way
central
offic
cough
neurocinin
substanc
p
neurocinin
b
would
neuromodulatori
search
anticough
central
action
antagonist
receiv
consequ
suffer
voluntari
control
cerebr
cortex
select
stimul
stapl
fiber
c
capsaicin
anim
gener
anesthesia
evok
human
be
impuls
cough
gener
preced
motor
act
cough
suppress
hand
psychogen
cough
answer
case
chronic
cough
infanc
provok
patient
reveal
without
tick
motor
vocal
ceas
effer
way
cough
pass
nerv
vacant
phrenic
spinal
motoneuron
expiratori
musculatur
result
characterist
sequenc
respiratori
movement
alreadi
exhaustingli
describ
consequ
protect
aerial
way
dynam
mechan
follow
comingofag
central
nervou
system
snc
suffer
influenc
hormon
neurohumor
factor
justborn
mammal
especi
prematur
presenc
secret
gastric
content
liquid
superior
aerial
way
vain
result
movement
deglutit
close
glotti
apnea
bradycardia
redistribut
sanguin
flow
vital
agenc
action
interleukin
snc
sensit
consequ
draw
would
explain
biggest
risk
sudden
death
neonat
infect
superior
aerial
way
iva
pig
youngl
observ
biochemist
chang
bioelectr
motoneuron
respiratori
first
month
life
gradual
diminish
occurr
deglutit
apnea
cough
start
main
protect
consequ
aerial
way
characterist
compon
remain
adult
human
be
sensit
consequ
cough
bigger
women
patient
iva
variant
cough
asthma
tussigen
asthma
given
controversi
effect
smoke
threshold
consequ
cough
studi
show
increas
threshold
smoker
perhap
central
peripher
action
nicotin
increas
thick
layer
respiratori
mucu
would
difficult
activ
receiv
becom
vacant
tracheobronchi
phenomenon
revers
week
reason
mani
peopl
complain
cough
stop
smoke
howev
smoke
suffer
chronic
cough
possibl
inflammatori
process
aerial
way
allevi
abstin
convert
enzym
angiotensin
eca
degrad
angiotensin
also
bradicinin
substanc
p
neurocinin
sensit
stapl
fiber
c
reason
patient
use
inhibit
antihypertens
eca
cough
collater
symptom
tend
disappear
four
week
interrupt
use
although
numer
affer
sensit
aerial
way
rat
mice
present
typic
motor
act
cough
make
difficult
evalu
thu
guinea
pig
speci
small
postag
use
experiment
work
cough
provok
direct
electr
micro
stimul
nucleu
solitari
treat
stimul
electricmechan
mucou
aerial
way
conscienti
anim
gener
anesthesia
much
experiment
work
much
physician
chemic
stimul
use
cough
agent
capsaicin
acid
citric
ascet
tartar
ultrason
nebul
distil
water
fog
capsaicin
caus
cough
use
manag
dose
project
doserepli
provok
cough
immedi
reason
recommend
evalu
effect
second
nebul
gener
paramet
analyz
studi
doserepli
concentr
capsaicin
capabl
provok
five
motor
act
cough
method
consid
reproduc
safe
human
be
individu
complain
transitori
pharynx
irrit
exposit
capsaicin
acid
citric
greater
probabl
caus
sensat
breathless
ardor
pharynx
ultrason
nebul
distil
water
insuffici
activ
consequ
cough
peopl
induc
bronchospasm
symptomat
other
reduc
reproduc
secur
method
studi
effect
anticough
suffer
bia
demulc
effect
stimul
saliva
secret
mucu
va
sugar
placebo
formul
voluntari
inhibit
cough
clinic
research
use
questionnair
burden
cough
questionnair
cough
specif
qualiti
life
questionnair
leicest
cough
questionnair
use
evalu
impact
cough
qualiti
life
dropropizin
levodropropizin
enantiom
reduc
sensit
stapl
fiber
c
becom
brazil
sever
present
boil
must
contain
sugar
present
dropropizin
tablet
tartrazin
yellow
colour
contraind
respect
diabet
peopl
intoler
acetylsalicyl
acid
dextromethorphan
clobutinol
cloperastin
fendizo
narcot
action
brainstem
dextromethorphan
agonist
receiv
opioid
antagonist
receiv
nmetildaspart
nmda
glutam
action
similar
one
acid
lsd
lsd
ketamin
psilocybin
dextromethorphan
metabol
cytochrom
enzym
individu
metabol
slowli
suscept
psychoact
effect
exactli
therapeut
dose
medicin
interact
inhibitor
mono
amin
oxidas
hand
inhibit
antidepress
reuptak
regist
fatal
poison
dextromethorphan
clobutinol
delay
ventricular
repolar
alreadi
relat
anaphylaxi
cloperastin
fendizo
sed
cough
also
peripher
action
desensit
affer
becom
vacant
tracheobronchi
interact
inhibitor
hand
anticough
narcot
morphin
codein
primarili
act
opioid
receiv
nucleu
solitari
treatment
guinea
pig
howev
naloxon
antagonist
receiv
hinder
anticough
action
codein
possibl
narcot
also
act
notopioid
receiv
perhap
glutam
serotonin
nociceptin
codein
one
anticough
effici
howev
commonli
provok
collater
effect
nausea
intestin
constip
caus
anticough
central
action
boost
effect
depressor
snc
alcohol
hypnot
sed
mani
case
chronic
cough
symptom
signal
gastroesophag
reflux
rge
inhibitor
proton
bomb
ibp
associ
prokinet
one
bromoprid
domperidon
commonli
prescrib
therapeut
test
howev
metaanalysi
random
control
studi
five
children
adult
indic
benefit
indiscrimin
use
ibp
chronic
hunt
et
al
evalu
adult
patient
chronic
cough
healthi
volunt
much
occurr
cough
measur
ph
condens
vapor
air
exhal
half
follow
hour
lemonad
ingest
declin
ph
minut
significantli
accent
individu
chronic
cough
volunt
eight
patient
cough
period
ph
exhal
air
remain
one
answer
therapi
made
ibp
one
month
pharmaceut
dose
dosag
specifi
research
suggest
appli
method
select
case
chronic
cough
detect
invas
form
acidif
va
gastroesophag
reflux
thu
prevent
unnecessari
use
ibp
guaifenesin
expector
glyceril
ether
guaiacol
resin
plant
guajacum
officinal
l
guaiacol
speci
confus
guaco
mikania
glomerata
spreng
whose
leav
popularli
use
brazil
prepar
infus
decaocto
combat
cough
guaifenesin
anticough
effect
patient
iva
inhibit
consequ
cough
submit
healthi
volunt
capsaicin
inhal
accur
mechan
action
complet
clarifi
frequent
advers
effect
chronic
headach
nausea
vomit
vasicin
origin
isol
alkali
leav
adhatoda
vasica
indic
ayurveda
also
leav
sida
cordifolia
l
malvacea
popularli
known
brazil
mauvewhit
contain
vasicin
hydrochlorid
bromhexin
synthet
deriv
vasicin
hydrochlorid
mucolyt
ambroxol
activ
metabolit
bromhexin
antirust
antiinflammatori
properti
surfact
local
anesthet
last
one
blockad
sodium
canal
advers
effect
nausea
vomit
abdomin
pain
coetan
erupt
super
dosag
provok
dyspneia
ataxia
ambroxol
approv
food
drug
administr
use
potassium
iodid
still
found
formular
expector
drawn
use
induc
hypothyroid
clinic
studi
show
monotherapi
n
acetylcystein
erdostein
anticough
effect
mucolyt
good
coadjut
treatment
respiratori
presum
antirust
commerci
mark
exempt
anticough
medic
laps
associ
dropropizin
levodropropizin
dextromethorphan
classic
antihistamin
diphenhydramin
doxylamin
formular
antihistamin
help
allevi
cough
thank
peripher
action
control
atopi
effect
snc
caus
consult
systemat
revis
prove
effect
methylxanthin
theophyllin
aminophyllin
caffein
antagonist
receiv
montelukast
either
superior
one
placebo
relief
cough
children
sinc
immemori
time
common
sens
recommend
honey
bee
relief
dri
cough
honey
demulc
contain
phenol
antirust
antimicrobi
cheap
safe
use
bigger
children
one
year
pasteur
rare
provok
allerg
random
studi
compar
effect
administr
minut
sleep
ml
honey
dextromethorphan
nocturn
cough
qualiti
sleep
children
adolesc
iva
one
third
group
patient
receiv
treatment
dextromethorphan
formul
order
similar
aspect
flavor
one
honey
particip
studi
could
distinguish
patient
use
honey
signific
reduct
nocturn
cough
comparison
receiv
treatment
benefit
gotten
anoth
random
work
analyz
effect
nocturn
dose
ml
honey
mg
dextromethorphan
mg
diphenhydramin
nasal
hygien
physiolog
serum
nocturn
cough
children
two
five
year
iva
frequenc
intens
nocturn
cough
accord
stori
parent
significantli
lesser
group
children
use
although
favor
result
scientif
consensu
indic
honey
therapi
acut
cough
esteem
half
patient
chronic
cough
present
degre
motor
dysfunct
vocal
fold
ppvv
larynx
dyskinesia
involuntari
paradox
suppli
ppvv
inspir
larynx
dyskinesia
unchain
inhal
irrit
smoke
vapor
low
temperatur
extrem
humid
air
motor
act
involv
respiratori
musculatur
physic
exercis
speak
laugh
deep
inspir
deglutit
patient
pulmonari
test
function
oxymetri
puls
gener
normal
cough
refractori
pharmacolog
treatment
anticough
antihistamin
inhibitor
proton
diagnosi
confirm
nasofibrolaryngoscopi
research
follow
two
month
adult
chronic
cough
medicin
feminin
sex
divid
group
randomli
control
submit
individu
session
phonoaudiolog
therapi
orient
vocal
hygien
exercis
abdomin
breath
voluntari
relax
larynx
musculatur
evalu
cough
vocal
qualiti
particip
analysi
acoust
electroglottographi
evidenc
signific
improv
group
submit
phonoaudiolog
murri
research
col
evalu
sensit
mucou
larynx
adult
chronic
cough
larynx
dyskinesia
refractori
symptom
laryngopharynx
reflux
treatment
ibp
nasofibrolaryngoscopi
made
three
month
treatment
ibp
manag
two
time
day
drug
dose
inform
combin
respiratori
retrain
exercis
acquisit
respiratori
rhythm
stimul
abdomin
breath
made
minut
two
time
day
threshold
consequ
adduc
ppvv
gotten
appli
air
puls
compress
changeabl
pressur
mucou
aryepiglott
fold
innerv
superior
laryng
nerv
visual
movement
adduc
ppvv
nasofibrolaryngoscopi
sensit
mucou
significantli
bigger
end
treatment
patient
complet
studi
present
cure
larynx
dyskinesia
cough
author
consid
edema
deriv
larynx
mucosa
acid
reflux
would
reduc
sensit
mechanoreceptor
becom
vacant
cough
adduc
ppvv
would
adapt
answer
defens
aerial
way
aspir
circumst
neurophysiolog
cough
complex
involv
activ
receiv
multipl
aerial
way
neural
project
nucleu
solitari
treatment
structur
central
nervou
system
unmask
physiopatholog
relat
cough
acidif
aerial
way
larynx
dyskinesia
field
instig
research
laryngolog
recent
studi
point
mani
patient
chronic
cough
sensit
neuropath
recurr
laryng
nerv
extend
understand
problem
open
perspect
therapeut
neuromodulatori
gabapentin
import
etiolog
diagnosi
cough
unquestion
howev
mani
sick
peopl
appeal
selfmed
anticough
mucolyt
request
doctor
prescrib
attenu
discomfort
identifi
caus
symptom
initi
specif
treatment
dextromethorphan
clobutinol
start
commerci
decad
sinc
remain
question
advantag
anticough
relat
placebo
succeed
stori
seriou
collater
effect
therefor
desir
brazilian
associ
medic
specialti
nation
agenc
sanitari
monitor
base
scientif
literatur
guid
profession
health
lay
public
act
next
manufactur
anticough
hinder
indiscrimin
use
product
prevent
poison
direct
conveni
standard
countri
pack
anticough
pediatr
use
becom
oblig
bottl
test
open
child
batcher
small
glass
although
innumer
experi
neuropharmacolog
cough
cellular
molecular
level
made
recent
year
clinic
research
new
effici
safe
anticough
disappoint
good
result
gotten
control
cough
experiment
model
alway
reproduc
human
be
incorpor
innov
recent
practic
clinic
continu
levodropropizin
launch
decad
clinic
studi
necessari
doubleblind
peopl
random
benefit
honey
bee
demulc
treatment
dri
cough
way
research
show
posit
impact
phonoaudiolog
therapi
case
refractori
chronic
cough
pharmacolog
treatment
encourag
accomplish
protocol
laryng
evalu
otolaryngologist
phonoaudiolog
confirm
necess
attend
multidisciplin
multiprofession
case
chronic
cough
better
assur
qualiti
life
patient
evid
anticough
exempt
medic
laps
superior
effect
one
placebo
relief
cough
also
proven
effect
guaifenesin
methylxanthin
montelukast
antihistamin
treatment
cough
children
phonoaudiolog
therapi
benefit
patient
refractori
chronic
cough
pharmacolog
treatment
